Currently, seven AMPs are allowed by the US Food and Drug Administration (FDA) for use in food market or in drug development for clinical use, with an increasing trend being the development and application of AMPs in the afore mentioned areas (Li et al. 2021 ; Datta and Roy 2021 ).
← all excerpts
Bifunctional peptides as alternatives to copper-based formulations to control citrus canker.
1
—
—